Your browser doesn't support javascript.
loading
Rapidly progressive congenital rhabdomyosarcoma presenting with multiple cutaneous lesions: an uncommon diagnosis and a therapeutic challenge.
Rekhi, Bharat; Qureshi, Sajid Shafique; Narula, Gaurav; Gujral, Sumeet; Kurkure, Purna.
Afiliação
  • Rekhi B; Department of Pathology, Tata Memorial Centre, Mumbai, Maharashtra, India. Electronic address: rekhi.bharat@gmail.com.
  • Qureshi SS; Department of Surgical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.
  • Narula G; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.
  • Gujral S; Department of Pathology, Tata Memorial Centre, Mumbai, Maharashtra, India.
  • Kurkure P; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.
Pathol Res Pract ; 210(5): 328-33, 2014 May.
Article em En | MEDLINE | ID: mdl-24635971
ABSTRACT
Congenital rhabdomyosarcomas (RMSs) are rare tumors with variable clinical presentations. A 2 month-old, term male neonate (37 weeks, 4 days), weighing 3.2kg, born to a 24 year-old primigravida, by simple vaginal delivery presented with multiple erythematous papulonodular lesions over his trunk that progressed to his whole body, on the first day of delivery. Prior to conception, his mother was treated for polycystic ovarian disease. On the tenth day, his chest computed tomogram scans revealed multiple, heterogeneously enhancing, bilateral pleural-based soft tissue density nodular lesions, along with multiple soft tissue density lesions, involving skeletal muscles of all his body parts. Microsections from two biopsies (on 10th day and after 2 months) revealed a malignant round cell tumor with cells arranged in a diffuse, solid pattern, comprising embryonal and solid alveolar components. Immunohistochemically, the tumor cells were diffusely positive for desmin, myoD1 and myogenin. Diagnosis of embryonal and alveolar (mixed type) RMS was offered. Further molecular cytogenetic analysis was negative for PAX3-FKHR and PAX7-FKHR. The patient was induced on chemotherapy as per intergroup rhabdomyosarcoma study IV protocol. There was treatment response with near total remission after 8 weeks of treatment. Thereafter, new lesions started appearing that also disappeared after modification of the chemotherapy drugs. However, after 16 months, the baby died of brain metastasis. The present case forms the fourth case report of an aggressive form of a congenital RMS with extensive cutaneous involvement and brain metastasis. A review of previously diagnosed cases of congenital RMSs is discussed herewith.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Neoplasias Cutâneas / Neoplasias de Tecidos Moles / Biomarcadores Tumorais Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans / Infant / Male Idioma: En Revista: Pathol Res Pract Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Neoplasias Cutâneas / Neoplasias de Tecidos Moles / Biomarcadores Tumorais Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans / Infant / Male Idioma: En Revista: Pathol Res Pract Ano de publicação: 2014 Tipo de documento: Article